Arbutus takes Comirnaty LNP patent fight to Canada and UPC ...
French drugmaker's Translate Bio unit accuses COVID rivals of infringing core lipid nanoparticle and mRNA purification ...
An enhanced agreement between the two countries cements existing protections for pharma innovators and is being hailed by the ...
Kevin Scott will lead the organisation representing in-house counsel in the UK, for companies such as AstraZeneca, Eli Lilly, ...
A high-profile hire will co-chair the firm's new office, bringing experience across biotech, therapeutics, genomics, diagnostics, and medical devices.
A Munich court ruled that Illumina infringed a rival’s DNA sequencing patents, handing the challenger an early victory in a dispute that is playing out across Europe and the US.
Regulation & Industry ...
Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the ...
China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer ...
UPC revives patent, but timing sinks Guardant’s appeal ...
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results